Tabula Rasa HealthCare

Tabula Rasa HealthCare Net Income

Delisted

The Net Income of Tabula Rasa HealthCare (TRHC) as of Nov 22, 2026 is -77.33 M USD. In the previous year, Net Income was -79.06 M USD — a change of -2.18% (higher).

Net Income

-77.33 MUSD

YoY

-2.18%

Last updated:

In 2022, Tabula Rasa HealthCare's profit amounted to -77.33 M USD, a -2.18% increase from the -79.06 M USD profit recorded in the previous year.

The Tabula Rasa HealthCare Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2019
-32.44 M USD
Jan 1, 2020
-80.97 M USD
Jan 1, 2021
-79.06 M USD
Jan 1, 2022
-77.33 M USD
Jan 1, 2023 (e)
-971,740.00 USD
Jan 1, 2024 (e)
6.07 M USD
Jan 1, 2025 (e)
-6.56 M USD
Jan 1, 2026 (e)
4,285.69 USD
The Tabula Rasa HealthCare Net Income history
YEARNet IncomeYoY
est4,285.69USD-100.07%
est-6.56 MUSD-208.00%
est6.07 MUSD-725.00%
est-971,740.00USD-98.74%
-77.33 MUSD-2.18%
-79.06 MUSD-2.36%
-80.97 MUSD+149.62%
-32.44 MUSD-31.38%
-47.27 MUSD-430.64%
14.30 MUSD-328.74%
-6.25 MUSD+118.23%
-2.86 MUSD+158.72%
-1.11 MUSD-71.40%
-3.87 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tabula Rasa HealthCare Revenue

Tabula Rasa HealthCare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
284.71 M USD
-28.83 M USD
-32.44 M USD
Jan 1, 2020
297.22 M USD
-57.74 M USD
-80.97 M USD
Jan 1, 2021
331.26 M USD
-69.32 M USD
-79.06 M USD
Jan 1, 2022
299.52 M USD
-67.91 M USD
-77.33 M USD
Jan 1, 2023 (e)
362.20 M USD
-27.95 M USD
-971,740.00 USD
Jan 1, 2024 (e)
416.43 M USD
-23.36 M USD
6.07 M USD
Jan 1, 2025 (e)
468.89 M USD
-65.12 M USD
-6.56 M USD
Jan 1, 2026 (e)
403.19 M USD
-6.61 M USD
4,285.69 USD

Tabula Rasa HealthCare Margins

Tabula Rasa HealthCare stock margins

The Tabula Rasa HealthCare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tabula Rasa HealthCare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tabula Rasa HealthCare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
36.30 %
-10.13 %
-11.39 %
Jan 1, 2020
31.09 %
-19.43 %
-27.24 %
Jan 1, 2021
29.56 %
-20.93 %
-23.86 %
Jan 1, 2022
22.34 %
-22.67 %
-25.82 %
Jan 1, 2023 (e)
22.34 %
-7.72 %
-0.27 %
Jan 1, 2024 (e)
22.34 %
-5.61 %
1.46 %
Jan 1, 2025 (e)
22.34 %
-13.89 %
-1.40 %
Jan 1, 2026 (e)
22.34 %
-1.64 %
0.00 %

Tabula Rasa HealthCare Stock analysis

What does Tabula Rasa HealthCare do? Tabula Rasa HealthCare Inc is a US-based company specializing in the development of innovative healthcare solutions. The company was founded in 2009 by CEO and Chairman Calvin H. Knowlton and is headquartered in Moorestown, New Jersey. The business model of Tabula Rasa Healthcare offers a wide range of technology solutions focused on improving clinical processes and patient safety. These technology solutions are incorporated into its medication management programs and include electronic medication profiles and clinical decision support systems. By adding SinfoniaRx, Tabula Rasa HealthCare is able to provide a holistic approach to improving medication adherence and compliance. The company offers a broad range of services to enable efficient monitoring of medication effects. Tabula Rasa HealthCare's technology enables personalized medication delivery to ensure that each patient receives the right medication at the right time. Tabula Rasa HealthCare operates in three business divisions: medication safety, medication therapy management, and population health management. In the field of medication safety, the company provides solutions that enable medical personnel to conduct a comprehensive assessment of a patient's medical history and create an accurate medication list. The company also offers support for risk assessment and medication management in patients with multiple or complex chronic conditions. The medication therapy management division covers a range of individual measures aimed at monitoring medication therapies. Tabula Rasa HealthCare's solutions assist healthcare professionals in better understanding patients' medication and improving treatment outcomes. In the population health management field, the company offers tools and strategies for optimizing communicative data analysis to minimize patient requirements and healthcare costs. The company provides technology solutions to revolutionize patient care through the integration of data analytics and a focus on preventive measures. This helps patients achieve better treatment outcomes, detect diseases at an early stage, and save costs. In summary, Tabula Rasa HealthCare Inc is a company focused on developing technology solutions to improve medical decision-making and maximize patient safety. The company utilizes its expertise in various areas and provides customized solutions to ensure personalized and optimized medication delivery. Its business model includes a holistic approach to improving medication adherence and compliance. Tabula Rasa HealthCare is driving medical research and the development of technology solutions to revolutionize modern patient care. Tabula Rasa HealthCare is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Tabula Rasa HealthCare's Profit Margins

The profit margins of Tabula Rasa HealthCare represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Tabula Rasa HealthCare's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Tabula Rasa HealthCare's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Tabula Rasa HealthCare's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Tabula Rasa HealthCare’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Tabula Rasa HealthCare stock

Net Income of Tabula Rasa HealthCare is -77.33 M USD in 2022.

Net Income of Tabula Rasa HealthCare changed from -79.06 M USD to -77.33 M USD, representing a -2.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Tabula Rasa HealthCare since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Tabula Rasa HealthCare historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Tabula Rasa HealthCare

All Key Metrics — Tabula Rasa HealthCare